Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2021

Month: December

Request Number: A-2021-000073

Request Summary: Adverse Drug Reactions (ADRs) for Mesalazine. Report numbers: E2B_03706888, E2B_03703577, E2B_03690817, E2B_03650148, E2B_03703572, 000934984, 000934900. ADRs for Vyvanse. Report numbers: 000933539, 000934356, 000934242, 000933957. ADR for Antihemophilic factor (recombinant). Report number: E2B_03664870. ADRs for C1 Esterase Inhibitor (Human). Report numbers: E2B_03673052, E2B_03667877, E2B_03698698. ADR for Gammagard Liquid. Report number: 000933632.

Disposition: Disclosed in part

Number of pages: 116

Date modified: